Literature DB >> 21286582

Complications of therapy in Parkinson's disease.

O S Kofman.   

Abstract

Despite several more effective combinations, the incidence of disability and intractable complications from levodopa therapy for Parkinson's disease is unchanged. Many of these appear to be related to the development of denervation hypersensitivity as well as to drug tolerance and loss of effect. They include dyskinesia, `wearing off' phenomenon, `on-off' phenomenon, and various psychic changes. More current forms of therapy with bromocriptine and drug holidays are described, emphasizing methods of preventing and controlling the incapacitating complications associated with long term drug therapy. Some future therapeutic considerations are also described.

Entities:  

Year:  1983        PMID: 21286582      PMCID: PMC2153537     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  Melanocyte-stimulating hormone and parkinsonism.

Authors:  S Shuster; A J Thody; S K Goolamali; J L Burton; N Plummer; D Bates
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

2.  Treatment of essential tremor with propranolol.

Authors:  T J Murray
Journal:  Can Med Assoc J       Date:  1972-11-18       Impact factor: 8.262

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Cross-species neural grafting in a rat model of Parkinson's disease.

Authors:  A Björklund; U Stenevi; S B Dunnett; F H Gage
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

5.  Lergotrile in Parkinson disease: further studies.

Authors:  A N Lieberman; G Gopinathan; E Estey; M Kupersmith; A Goodgold; M Goldstein
Journal:  Neurology       Date:  1979-02       Impact factor: 9.910

6.  Complications of chronic levodopa therapy: long-term efficacy of drug holiday.

Authors:  W C Koller; W J Weiner; S Perlik; P A Nausieda; C G Goetz; H L Klawans
Journal:  Neurology       Date:  1981-04       Impact factor: 9.910

7.  Further studies with pergolide in Parkinson disease.

Authors:  A N Lieberman; M Goldstein; G Gopinathan; M Leibowitz; A Neophytides; R Walker; E Hiesiger; J Nelson
Journal:  Neurology       Date:  1982-10       Impact factor: 9.910

8.  Lisuride in parkinsonism.

Authors:  J D Parkes; M Schachter; C D Marsden; B Smith; A Wilson
Journal:  Ann Neurol       Date:  1981-01       Impact factor: 10.422

9.  Treatment of Parkinson's disease with L-dopa: a current appraisal.

Authors:  O Kofman
Journal:  Can Med Assoc J       Date:  1971-03-20       Impact factor: 8.262

  9 in total
  1 in total

1.  The therapeutic potential of stem cells and progenitor cells for the treatment of Parkinson's disease.

Authors:  Mooi Tiong Liau; Farahnaz Amini; Thamil Selvee Ramasamy
Journal:  Tissue Eng Regen Med       Date:  2016-10-20       Impact factor: 4.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.